Healthcare -
Biotechnology - NASDAQ - US
$ 1.74
6.75 %
$ 91.8 M
Market Cap
-0.59
P/E
ALXO - OPERATING EXPENSES
Operating Expenses ALXO - ALX Oncology Holdings Inc.
170 M
LAST VALUE
42.76%
2 YEAR CAGR
65.12%
5 YEAR CAGR
0.00%
10 YEAR CAGR